HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tetley, T. D. Search for Related Content PubMed PubMed Citation Articles by Tetley, T. D.

Macrophages and the Pathogenesis of COPD^*

^* From the National Heart & Lung Institute, Imperial College, London, UK.

Correspondence to: Teresa D. Tetley, PhD, National Heart & Lung Institute, Imperial College London, SW3 6LY, United Kingdom; e-mail: t.tetley{at}ic.ac.uk

Macrophages are long-lived effector cells within the lung. They are reactive, responding to endogenous and exogenous stimuli, as well as proactive, producing mediators that modulate the behavior of surrounding cells. In addition, they play a critical role in the clearance of apoptotic neutrophils. Their role in COPD probably reflects a number of functional properties. However, if the link between increased proteinase burden and tissue destruction and injury in patients with COPD is correct, then macrophages must be very significant. Even though other cells, including epithelial cells and fibroblasts, have been shown to express higher matrix metalloproteinase (MMP) levels in lung tissue from subjects with COPD and emphysema, the numbers of resident cells do not appear to increase by the same factor as that of sequestered macrophages. The combination of a 5- to 10-fold increase in macrophage numbers, the up-regulation of MMPs, and their corelease with other classes of stored proteinases must be highly significant in terms of an increase in proteinase potential in the small airways and respiratory units. This may account for increased tissue destruction and inflammatory mediator activation leading to the pathology that occurs during COPD. Since only about 15% of smokers develop clinically significant disease, it seems likely, in smokers without COPD, that these processes either are strictly controlled or that lung repair mechanisms are more effective.

Key Words: cigarette smoke • COPD • elastase • emphysema • macrophage • matrix metalloproteinase • neutrophil

This article has been cited by other articles:

				E. Adelroth, U. Hedlund, A. Blomberg, R. Helleday, M-C. Ledin, J. O. Levin, J. Pourazar, T. Sandstrom, and B. Jarvholm Airway inflammation in iron ore miners exposed to dust and diesel exhaust Eur. Respir. J., April 1, 2006; 27(4): 714 - 719. [Abstract] [Full Text] [PDF]

				R. Buhl and S. G. Farmer Future Directions in the Pharmacologic Therapy of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 83 - 93. [Abstract] [Full Text] [PDF]

				A. Punturieri, R. S. Alviani, T. Polak, P. Copper, J. Sonstein, and J. L. Curtis Specific Engagement of TLR4 or TLR3 Does Not Lead to IFN-{beta}-Mediated Innate Signal Amplification and STAT1 Phosphorylation in Resident Murine Alveolar Macrophages J. Immunol., July 15, 2004; 173(2): 1033 - 1042. [Abstract] [Full Text] [PDF]

				B. N. Melgert, D. S. Postma, M. Geerlings, M. A. Luinge, P. A. Klok, B. W. A. van der Strate, H. A. M. Kerstjens, W. Timens, and M. N. Hylkema Short-Term Smoke Exposure Attenuates Ovalbumin-Induced Airway Inflammation in Allergic Mice Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 880 - 885. [Abstract] [Full Text] [PDF]

				D. Massaro, G. D. Massaro, A. Baras, E. P. Hoffman, and L. B. Clerch Calorie-related rapid onset of alveolar loss, regeneration, and changes in mouse lung gene expression Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L896 - L906. [Abstract] [Full Text] [PDF]

				R. Buhl and S. G. Farmer Current and Future Pharmacologic Therapy of Exacerbations in Chronic Obstructive Pulmonary Disease and Asthma Proceedings of the ATS, April 1, 2004; 1(2): 136 - 142. [Abstract] [Full Text] [PDF]

				C. Neurohr, A-G. Lenz, I. Ding, H. Leuchte, T. Kolbe, and J. Behr Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokers Eur. Respir. J., July 1, 2003; 22(1): 82 - 87. [Abstract] [Full Text] [PDF]

				G. L. Snider Understanding Inflammation in Chronic Obstructive Pulmonary Disease: The Process Begins Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1045 - 1046. [Full Text] [PDF]